Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Anticytokine therapies in systemic lupus erythematosus.

La Cava A.

Immunotherapy. 2010 Jul;2(4):575-82. doi: 10.2217/imt.10.29. Review.

2.

Antibody-based therapies in systemic lupus erythematosus.

Iikuni N, La Cava A.

Mini Rev Med Chem. 2009 Jun;9(7):829-46. Review.

PMID:
19519508
3.

Cytokines as therapeutic targets in SLE.

Rönnblom L, Elkon KB.

Nat Rev Rheumatol. 2010 Jun;6(6):339-47. doi: 10.1038/nrrheum.2010.64. Epub 2010 May 4. Review.

PMID:
20440285
4.

Lupus, the current therapeutic approaches.

Wong M, La Cava A.

Drugs Today (Barc). 2011 Apr;47(4):289-302. doi: 10.1358/dot.2011.47.4.1583186. Review.

PMID:
21573252
5.

Anticytokine therapy in systemic lupus erythematosus.

Yoo DH.

Lupus. 2010 Oct;19(12):1460-7. doi: 10.1177/0961203310376955. Review.

PMID:
20947558
6.

Anti-cytokine therapy in systemic lupus erythematosus.

Smolen JS, Steiner G, Aringer M.

Lupus. 2005;14(3):189-91. Review.

PMID:
15807194
7.

Monoclonal antibodies in the treatment of systemic lupus erythematosus.

Robak E, Robak T.

Curr Drug Targets. 2009 Jan;10(1):26-37. Review.

PMID:
19149533
8.

Biologicals for the treatment of systemic lupus erythematosus?

Gunnarsson I, van Vollenhoven RF.

Ann Med. 2012 May;44(3):225-32. doi: 10.3109/07853890.2011.561362. Epub 2011 Apr 15. Review.

PMID:
21495789
9.

New biologic therapy for systemic lupus erythematosus.

Ding HJ, Gordon C.

Curr Opin Pharmacol. 2013 Jun;13(3):405-12. doi: 10.1016/j.coph.2013.04.005. Epub 2013 May 7. Review.

PMID:
23664092
10.

Interleukin-17 in systemic lupus erythematosus: A comprehensive review.

Li D, Guo B, Wu H, Tan L, Chang C, Lu Q.

Autoimmunity. 2015;48(6):353-61. doi: 10.3109/08916934.2015.1037441. Epub 2015 Apr 20. Review.

PMID:
25894789
11.

Therapeutic potential of IL-27 in systemic lupus erythematosus.

Pan HF, Tao JH, Ye DQ.

Expert Opin Ther Targets. 2010 May;14(5):479-84. doi: 10.1517/14728221003769911. Review.

PMID:
20350048
12.

The biology behind the new therapies for SLE.

Ermann J, Bermas BL.

Int J Clin Pract. 2007 Dec;61(12):2113-9. Review.

PMID:
17997810
13.

Novel therapeutic approaches in systemic lupus erythematosus.

Kiss E, Szodoray P.

Front Biosci (Schol Ed). 2010 Jan 1;2:221-8. Review.

PMID:
20036942
14.

[Biologics therapy for systemic lupus erythematosus. Current situation].

Hoyer BF, Dörner T.

Z Rheumatol. 2015 Apr;74(3):206-14. doi: 10.1007/s00393-014-1458-0. Review. German.

PMID:
25854155
15.

Update on B-cell targeted therapies for systemic lupus erythematosus.

Mok CC.

Expert Opin Biol Ther. 2014 Jun;14(6):773-88. doi: 10.1517/14712598.2014.895810. Epub 2014 Mar 4. Review.

PMID:
24588110
16.

Targeting the interferon pathway with sifalimumab for the treatment of systemic lupus erythematosus.

Greth W, Robbie GJ, Brohawn P, Hultquist M, Yao B.

Immunotherapy. 2017 Jan;9(1):57-70. doi: 10.2217/imt-2016-0090. Review.

PMID:
28000522
17.

Belimumab: review of use in systemic lupus erythematosus.

Boyce EG, Fusco BE.

Clin Ther. 2012 May;34(5):1006-22. doi: 10.1016/j.clinthera.2012.02.028. Epub 2012 Mar 30. Review.

PMID:
22464040
18.

Systemic lupus erythematosus: pharmacological developments and recommendations for a therapeutic strategy.

Pego-Reigosa JM, Isenberg DA.

Expert Opin Investig Drugs. 2008 Jan;17(1):31-41. Review.

PMID:
18095917
19.

B-cell-targeted therapy for systemic lupus erythematosus: an update.

Ding C, Foote S, Jones G.

BioDrugs. 2008;22(4):239-49. Review.

PMID:
18611066
20.

B-cell targeted treatments for lupus: the journey counts as much as the destination.

Falgarone G, Dhote R, Boissier MC.

Joint Bone Spine. 2012 Oct;79(5):437-40. doi: 10.1016/j.jbspin.2012.02.010. Epub 2012 Apr 4. Review.

PMID:
22480746

Supplemental Content

Support Center